Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.6 USD | +0.99% | +5.24% | -24.85% |
May. 15 | Legend Expects to Log Profit in 2026 | MT |
May. 14 | HC Wainwright Adjusts Price Target on Legend Biotech to $86 From $87, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.85% | 8.23B | |
+9.78% | 115B | |
+11.91% | 106B | |
-2.74% | 21.96B | |
-13.96% | 21.87B | |
-5.29% | 19.21B | |
-3.02% | 18.08B | |
-38.57% | 17.71B | |
+6.41% | 14.32B | |
+35.11% | 12.42B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Johnson & Johnson, Legend Biotech's Carvykti Receives FDA Approval to Treat Relapsed, Refractory Multiple Myeloma